natgillin/translations-raw huggingface dataset:
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated in an assessment report reviewed within the Standing Committee on Biocidal Products on 13 March 2014.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile 13. marca 2014 ugotovitve pregleda v Stalnem odboru za biocidne pripravke vključene v poročilo o oceni.
According to that assessment report, biocidal products used for product-type 19 and containing ethyl butylacetylaminopropionate may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC, provided that the certain specifications and conditions relating to its use are satisfied.
Glede na navedeno poročilo o oceni je za biocidne proizvode, ki se uporabljajo v 19. vrsti proizvodov in vsebujejo etil butil acetil aminopropionat, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES, če so skladni z nekaterimi specifikacijami in pogoji v zvezi z njihovo uporabo.
It is therefore appropriate to approve ethyl butylacetylaminopropionate for use in biocidal products for product-type 19 subject to compliance with such specifications and conditions.
Zato je primerno odobriti etil butil acetil aminopropionat za uporabo v biocidnih proizvodih 19. vrste proizvodov, pri čemer se upoštevajo takšne specifikacije in pogoji.
Since the evaluation did not address nanomaterials, the approval should not cover such materials in accordance with Article 4(4) of Regulation (EU) No 528/2012.
Ker presoja ni obravnavala nanomaterialov, odobritev v skladu s členom 4(4) Uredbe (EU) št. 528/2012 ne bi smela zajemati takšnih materialov.
Ethyl butylacetylaminopropionate shall be approved as an active substance for use in biocidal products for product-type 19, subject to the specifications and conditions set out in the Annex.
Etil butil acetil aminopropionat se odobri kot aktivna snov za uporabo v biocidnih proizvodih 19. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
Ethyl butylacetylaminopropionate
Etil butil acetil aminopropionat
3-(N-acetyl-N-butyl)aminopropionic acid ethyl ester
3-(N-acetil-N-butil)aminopropionska kislina etil ester
EC no: 257-835-0
Št.
CAS no: 52304-36-6
ES: 257-835-0
1 November 2015
Št.
31 October 2025
CAS: 52304-36-6
Authorisations are subject to the following condition:
31. oktober 2025
Primary exposure of humans to the product shall be minimized by considering and applying appropriate risk mitigation measures, including, where applicable, instructions on the amount and the frequency with which the product may be applied to human skin.
Pri oceni proizvoda je treba posebno pozornost nameniti vidikom izpostavljenosti, tveganja in učinkovitosti, povezanim s katero koli uporabo, zajeto v vlogi za izdajo dovoljenja, ki niso bili obravnavani v oceni tveganja aktivne snovi na ravni Unije.
The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 8 of Regulation (EU) No 528/2012.
Dovoljenja se izdajo pod naslednjimi pogoji:
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
osnovna izpostavljenost ljudi proizvodu se minimizira z upoštevanjem in uporabo ustreznih ukrepov za zmanjšanje tveganja, vključno z navodili za količino in pogostost nanosa proizvoda na človeško kožo, kadar je to ustrezno.
For the implementation of the common principles of Annex VI to Regulation (EU) No 528/2012, the content and conclusions of assessment reports are available on the Commission website: http://ec.europa.eu/comm/environment/biocides/index.htm
Čistost, navedena v tem stolpcu, je bila minimalna stopnja čistosti aktivne snovi, uporabljene za presojo v skladu s členom 8 Uredbe (EU) št. 528/2012.
Commission Implementing Regulation (EU) No 407/2014
Izvedbena uredba Komisije (EU) št. 407/2014
approving transfluthrin as an existing active substance for use in biocidal products for product-type 18
o odobritvi transflutrina kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 18. vrste proizvodov
That list includes transfluthrin.
Navedeni seznam vključuje transflutrin.
Transfluthrin has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that Directive, which corresponds to product-type 18 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 11(2) Direktive 98/8/ES je bila opravljena presoja transflutrina glede uporabe v 18. vrsti proizvodov (insekticidih, akaricidih in pripravkih za nadzor drugih členonožcev), kot je opredeljena v Prilogi V k navedeni direktivi, ki ustreza vrsti proizvodov 18, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
The Netherlands was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 13 July 2010 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Nizozemska, ki je bila imenovana za državo članico poročevalko, je 13. julija 2010 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji predložila poročilo pristojnega organa in priporočilo.
According to that assessment report, biocidal products used for product-type 18 and containing transfluthrin may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC, provided that certain specifications and conditions relating to its use are satisfied.
Glede na navedeno poročilo o oceni je za biocidne pripravke, ki se uporabljajo v 18. vrsti proizvodov in vsebujejo transflutrin, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES, če so skladni z nekaterimi specifikacijami in pogoji v zvezi z njihovo uporabo.
It is therefore appropriate to approve transfluthrin for use in biocidal products for product-type 18 subject to compliance with such specifications and conditions.
Zato je primerno odobriti transflutrin za uporabo v biocidnih proizvodih 18. vrste proizvodov, pri čemer se upoštevajo takšne specifikacije in pogoji.
Since the evaluation did not address nanomaterials, the approval should not cover such materials pursuant to Article 4(4) of Regulation (EU) No 528/2012.
Ker presoja ni obravnavala nanomaterialov, odobritev v skladu s členom 4(4) Uredbe (EU) št. 528/2012 ne bi smela zajemati takšnih materialov.
Transfluthrin shall be approved as an active substance for use in biocidal products for product-type 18, subject to the specifications and conditions set out in the Annex.
Transflutrin se odobri kot aktivna snov za uporabo v biocidnih proizvodih 18. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
IUPAC name
Poimenovanje po IUPAC
2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
2,3,5,6-tetrafluorobenzil (1R,3S)-3-(2,2-diklorovinil)-2,2-dimetilciklopropankarboksilat
EC No: 405-060-5
Št.
CAS No: 118712-89-3
ES: 405-060-5
965 g/kg of 1R trans configuration
Št.
1 November 2015
CAS: 118712-89-3
31 October 2025
965 g/kg 1R trans konfiguracije
In view of the risks for water, sediment and soil compartments, transfluthrin shall not be used in vaporisers for indoor use or insecticidal coils unless it can be demonstrated in the application for product authorisation that risks can be reduced to an acceptable level.
Pri oceni proizvoda je treba posebno pozornost nameniti vidikom izpostavljenosti, tveganja in učinkovitosti, povezanim s katero koli uporabo, zajeto v vlogi za izdajo dovoljenja, ki niso bili obravnavani v oceni tveganja aktivne snovi na ravni Unije.
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
glede na tveganje za vodo, usedline in tla se transflutrin ne uporablja v vlažilnikih zraka za uporabo v zaprtih prostorih ali insekticidnih spiralah, razen če se v vlogi za izdajo dovoljenja lahko dokaže, da je tveganje mogoče zmanjšati na sprejemljivo raven.
Commission Implementing Regulation (EU) No 408/2014
Izvedbena uredba Komisije (EU) št. 408/2014
approving synthetic amorphous silicon dioxide as an existing active substance for use in biocidal products for product-type 18
o odobritvi sintetičnega amorfnega silicijevega dioksida kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 18. vrste proizvodov
That list includes silicon dioxide.
Navedeni seznam vključuje silicijev dioksid.
Silicon dioxide has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that Directive, which corresponds to product-type 18 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 11(2) Direktive 98/8/ES je bila opravljena ocena silicijevega dioksida glede uporabe v 18. vrsti proizvodov (insekticidi, akaricidi in pripravki za nadzor drugih členonožcev), kot je opredeljena v Prilogi V k navedeni direktivi, ki ustreza 18. vrsti proizvodov, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
The data submitted for the purpose of the evaluation allowed conclusions to be drawn only regarding a certain form of silicon dioxide, i.e. synthetic amorphous silicon dioxide described as wet silica CAS No 112926-00-8.
Podatki, ki so bili predloženi za namen ocene, so omogočili sprejetje sklepov samo glede določene oblike silicijevega dioksida, tj. sintetičnega amorfnega silicijevega dioksida, opisanega kot mokri silicij št.
The evaluation did not allow conclusions to be drawn regarding any other substance complying with the definition of silicon dioxide CAS No 7631-86-9 in the abovementioned list of active substances in Regulation (EC) No 1451/2007.
CAS 112926-00-8.
Therefore, only synthetic amorphous silicon dioxide should be covered by the approval.
Na podlagi ocene ni bilo mogoče sprejeti sklepov glede drugih snovi, ki so skladne z opredelitvijo silicijevega dioksida, št.
France was designated as rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 16 April 2009 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
CAS 7631-86-9, z navedenega seznama aktivih snovi iz Uredbe (ES) št. 1451/2007.
The competent authority report was reviewed by the Member States and the Commission.
Zato bi odobritev morala zajemati samo sintetični amorfni silicijev dioksid.
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated in an assessment report reviewed within the Standing Committee on Biocidal Products on 13 March 2014.
Francija, ki je bila imenovana za državo članico poročevalko, je 16. aprila 2009 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
According to that assessment report, biocidal products used for product-type 18 and containing synthetic amorphous silicon dioxide may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC, provided that certain specifications and conditions relating to its use are satisfied.
Države članice in Komisija so pregledale poročilo pristojnega organa.
It is therefore appropriate to approve synthetic amorphous silicon dioxide for use in biocidal products for product-type 18 subject to compliance with such specifications and conditions.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile ugotovitve pregleda 13. marca 2014 v Stalnem odboru za biocidne pripravke vključene v poročilo o oceni.
Since synthetic amorphous silicon dioxide as evaluated is a nanomaterial, the approval should cover such nanomaterials pursuant to Article 4(4) of Regulation (EU) No 528/2012 provided that certain specifications and conditions relating to their use are satisfied.
Iz navedenega poročila o oceni je razvidno, da je za biocidne pripravke, ki se uporabljajo za 18. vrsto proizvodov in vsebujejo sintetični amorfni silicijev dioksid, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES, če so izpolnjene določene specifikacije in pogoji glede njihove uporabe.
A reasonable period should be allowed to elapse before an active substance is approved, in order to permit interested parties to take the preparatory measures necessary to meet the new requirements laid down.
Zato je primerno odobriti sintetični amorfni silicijev dioksid za uporabo v biocidnih pripravkih 18. vrste proizvodov, pod pogojem, da je to v skladu s takšnimi specifikacijami in pogoji.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,
Ker je bil sintetični amorfni silicijev dioksid ocenjen kot nanomaterial, bi odobritev morala zajemati takšne nanomateriale v skladu s členom 4(4) Uredbe (EU) št. 528/2012, če so izpolnjene določene specifikacije in pogoji glede njihove uporabe.
HAS ADOPTED THIS REGULATION:
Pred odobritvijo aktivne snovi bi bilo treba zagotoviti ustrezno obdobje, v katerem bi deležniki lahko sprejeli potrebne pripravljalne ukrepe za izpolnitev novih zahtev.
Article 1
Ukrepi iz te uredbe so v skladu z mnenjem Stalnega odbora za biocidne pripravke –
Synthetic amorphous silicon dioxide shall be approved as an active substance for use in biocidal products for product-type 18, subject to the specifications and conditions set out in the Annex.
SPREJELA NASLEDNJO UREDBO:
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Sintetični amorfni silicijev dioksid se odobri kot aktivna snov za uporabo v biocidnih proizvodih 18. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Člen 2
Done at Brussels, 23 April 2014.
Ta uredba začne veljati dvajseti dan po objavi v Uradnem listu Evropske unije.
For the Commission
Ta uredba je v celoti zavezujoča in se neposredno uporablja v vseh državah članicah.
The President
V Bruslju, 23. aprila 2014
OJ L 167, 27.6.2012, p. 1.
Za Komisijo
Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (OJ L 325, 11.12.2007, p. 3).
Predsednik
ANNEX
Uredba Komisije (ES) št. 1451/2007 z dne 4. decembra 2007 o drugi fazi desetletnega delovnega programa iz člena 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta o dajanju biocidnih pripravkov v promet (UL L 325, 11.12.2007, str. 3).
Common Name
Direktiva 98/8/ES Evropskega parlamenta in Sveta z dne 16. februarja 1998 o dajanju biocidnih pripravkov v promet (UL L 123, 24.4.1998, str. 1).
IUPAC Name
PRILOGA
Identification Numbers
Splošno ime
Minimum degree of purity of the active substance [1]
Ime po IUPAC
Reference structural characteristics [2]
Identifikacijska številka
Expiry date of approval
Referenčne strukturne značilnosti [2]
Product type
Datum odobritve
Specific conditions [3]
Datum prenehanja veljavnosti odobritve
Synthetic amorphous silicon dioxide (nano)
Vrsta proizvoda
IUPAC Name:
Posebni pogoji [3]
Silicon dioxide
Sintetični amorfni silicijev dioksid
EC No: 231-545-4
Ime po IUPAC:
CAS No: 112926-00-8
Silicijev dioksid
This approval covers synthetic amorphous silicon dioxide as a nanomaterial in the form of stable aggregated particles of particle size > 1 μm, with primary particles of nanosize.
Št.
Size of stable aggregated particles > 1 μm
ES: 231-545-4
Primary particle size < 25 nm
Št.
1 November 2015
Ta odobritev zajema sintetični amorfni silicijev dioksid kot nanomaterial v obliki stabilnih združenih delcev velikosti > 1 μm, s primarnimi delci nano velikosti.
31 October 2025
Velikost stabilnih združenih delcev > 1 μm
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.
Primarni delec velikosti < 25 nm
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
1. november 2015
The structural characteristics indicated in this column were the ones of the active substance used for the evaluation made in accordance with Article 8 of Regulation (EU) No 528/2012.
31. oktober 2025
800 g/kg
Strukturne značilnosti, navedene v tem stolpcu, ustrezajo strukturnim značilnostim tiste aktivne snovi, ki je bila uporabljena za oceno v skladu s členom 8 Uredbe (EU) št. 528/2012.
The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 8 of Regulation (EU) No 528/2012.
Za izvajanje splošnih načel iz Priloge VI k Uredbi (EU) št. 528/2012 so vsebina in sklepne ugotovitve poročil o oceni na voljo na naslednjem spletišču Komisije: http://ec.europa.eu/comm/environment/biocides/index.htm.
Commission Implementing Regulation (EU) No 409/2014
Izvedbena uredba Komisije (EU) št. 409/2014
entering a name in the register of traditional specialities guaranteed (Bacalhau de Cura Tradicional Portuguesa (TSG))
o vpisu imena v register zajamčenih tradicionalnih posebnosti (Bacalhau de Cura Tradicional Portuguesa (ZTP))
Pursuant to Article 50(2)(b) of Regulation (EU) No 1151/2012, Portugal's application to register the name ‘Bacalhau de Cura Tradicional Portuguesa’ was published in the Official Journal of the European Union [2].
V skladu s členom 50(2)(b) Uredbe (EU) št. 1151/2012 je bila vloga Portugalske za registracijo imena „Bacalhau de Cura Tradicional Portuguesa“ objavljena v Uradnem listu Evropske unije [2].
As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Bacalhau de Cura Tradicional Portuguesa’ should therefore be entered in the register,
Ker v skladu s členom 51 Uredbe (EU) št. 1151/2012 Komisija ni prejela nobene izjave o ugovoru, bi bilo treba ime „Bacalhau de Cura Tradicional Portuguesa“ registrirati –
The name ‘Bacalhau de Cura Tradicional Portuguesa’ (TSG) is hereby entered in the register.
Ime „Bacalhau de Cura Tradicional Portuguesa“ (ZTP) se registrira.
The name referred to in the first paragraph identifies a product in Class 1.7.
Ime iz prvega odstavka opredeljuje proizvod skupine 1.7 Sveže ribe, mehkužci in raki ter iz njih pridobljeni proizvodi iz Priloge II k Uredbi Komisije (ES) št. 1216/2007 [3].Člen 2
Fresh fish, molluscs and crustaceans and products derived therefrom of Annex II to Commission Regulation (EC) No 1216/2007 [3].Article 2
Ta uredba začne veljati dvajseti dan po objavi v Uradnem listu Evropske unije.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
V Bruslju, 23. aprila 2014
Done at Brussels, 23 April 2014.
Za Komisijo
The President
UL L 343, 14.12.2012, str. 1.
OJ L 343, 14.12.2012, p. 1.
UL C 292, 8.10.2013, str. 8.
OJ C 292, 8.10.2013, p. 8.
Uredba Komisije (ES) št. 1216/2007 z dne 18. oktobra 2007 o določitvi podrobnih pravil za izvajanje Uredbe Sveta (ES) št. 509/2006 o zajamčenih tradicionalnih posebnostih kmetijskih proizvodov in živil (UL L 275, 19.10.2007, str. 3).
Commission Implementing Regulation (EU) No 410/2014
Izvedbena uredba Komisije (EU) št. 410/2014
amending Implementing Regulation (EU) No 293/2012 as regards the monitoring of CO2 emissions from new light commercial vehicles type-approved in a multi-stage process
o spremembi Izvedbene uredbe (EU) št. 293/2012 v zvezi s spremljanjem emisij CO2 iz novih lahkih gospodarskih vozil, homologiranih s postopkom večstopenjske homologacije
Having regard to Regulation (EU) No 510/2011 of the European Parliament and of the Council of 11 May 2011 setting emission performance standards for new light commercial vehicles as part of the Union's integrated approach to reduce CO2 emissions from light-duty vehicles [1], and in particular the first subparagraph of Article 8(9) thereof,
ob upoštevanju Uredbe (EU) št. 510/2011 Evropskega parlamenta in Sveta z dne 11. maja 2011 o določitvi standardov emisijskih vrednosti za nova lahka gospodarska vozila kot del celostnega pristopa Unije za zmanjšanje emisij CO2 iz lahkih tovornih vozil [1] in zlasti prvega pododstavka člena 8(9) Uredbe,
Annex XII to Commission Regulation (EC) No 692/2008 [2] sets out a new method for determining the CO2 emissions from and fuel consumption of N1 vehicles which are type-approved in a multi-stage process (hereinafter referred to as ‘multi-stage vehicles’).
Priloga XII k Uredbi Komisije (ES) št. 692/2008 [2] določa novo metodologijo za določanje emisij CO2 in porabe goriva za vozila N1, homologirana s postopkom večstopenjske homologacije (v nadaljnjem besedilu: večstopenjska vozila).
That new method is to apply from 1 January 2014 but may be applied on a voluntary basis since 1 January 2013.
Nova metodologija se uporablja od 1. januarja 2014, ampak se lahko izvaja prostovoljno od 1. januarja 2013.
Point 7 of Part B of Annex II to Regulation (EU) No 510/2011 provides that the specific emissions of CO2 of completed vehicles are to be allocated to the manufacturer of the base vehicle.
Točka 7 dela B Priloge II k Uredbi (EU) št. 510/2011 določa, da se specifične emisije CO2 dodelanih vozil dodelijo proizvajalcu osnovnega vozila.
This requires that completed vehicles can be recognised in the monitoring process and that the manufacturer of the base vehicle can be identified.
Zato je treba dodelana vozila prepoznati v postopku spremljanja in identificirati proizvajalca osnovnega vozila.
It also requires certain data relating to the base vehicle to be determined in accordance with the new methodology set out in Annex XII to Regulation (EC) No 692/2008.
Prav tako so potrebni določeni podatki, ki se nanašajo na osnovno vozilo in ki jih je treba določiti v skladu z novo metodologijo iz Priloge XII k Uredbi (ES) št. 692/2008.
The manufacturers of the base vehicles have, in accordance with Article 8(5) of Regulation (EU) No 510/2011, the right to verify the data relating to a multi-stage vehicle, on the basis of which their specific CO2 emission targets are calculated.
Proizvajalci osnovnega vozila imajo v skladu s členom 8(5) Uredbe (EU) št. 510/2011 pravico preveriti podatke o večstopenjskem vozilu, na podlagi katerih so izračunani cilji specifičnih emisij CO2.
It is therefore appropriate to lay down detailed provisions on the exchange of relevant data between the manufacturers and the Commission.
Zato je primerno, da se določijo podrobne določbe o izmenjavi ustreznih informacij med proizvajalci in Komisijo.
Due to the specificities and design of their vehicle registration systems, Member States may however not be able to provide all the data relevant for the monitoring of multi-stage vehicles that are indicated in the detailed data specified in Annex II to Regulation (EU) No 510/2011.
Zaradi posebnosti in zasnove sistemov registracije vozil države članice morda ne morejo zagotoviti vseh podatkov za spremljanje večstopenjskih vozil, ki so navedeni v podrobnih podatkih iz Priloge II k Uredbi (EU) št. 510/2011.
As a consequence, the Commission should have the possibility to take into account data provided by manufacturers as part of the verification process pursuant to Article 8(5) of Regulation (EU) No 510/2011 for determining the preliminary specific emissions targets.
Zato bi Komisija morala imeti pri določanju začasnih ciljev specifičnih emisij možnost, da upošteva podatke, ki jih zagotovijo proizvajalci kot del postopka preverjanja v skladu s členom 8(5) Uredbe (EU) št. 510/2011.